Nivolumab/pembrolizumabVarious toxicities: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1734卷 / 1期

关键词：

D O I：

10.1007/s40278-019-56504-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：379 / 379

相关论文

共 50 条

[1] Nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2020, 1786 (1) : 131 - 131
[2] Nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2025, 2047 (1) : 352 - 352
[3] Nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2021, 1848 (1) : 310 - 310
[4] Nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2019, 1756 (1) : 259 - 260
[5] Ipilimumab/nivolumab/pembrolizumabVarious toxicities : 5 case reports
Reactions Weekly, 2024, 2019 (1) : 231 - 231
[6] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2020, 1813 (1) : 140 - 140
[7] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2020, 1800 (1) : 180 - 180
[8] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2020, 1834 (1) : 143 - 143
[9] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2019, 1745 (1) : 164 - 165
[10] Durvalumab/nivolumab/pembrolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2018, 1683 (1) : 273 - 273

← 1 2 3 4 5 →